Clinical trial shows promising results for inciting production of neutralizing antibodies in HIV vaccine

Corporate businessmen working on tablet at office

A large team of researchers affiliated with a host of institutions across the U.S., working with two colleagues from Sweden, reports promising results in a phase I clinical trial aimed at testing the efficacy and safety of an HIV vaccine.

New Mechanism for “Giant” Greigite Growth in Deep-Sea Sediments

Previous article

What do midterm elections mean for Trump’s 2024 run?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations